213 related articles for article (PubMed ID: 31132889)
1. Selective COX-2 inhibitors as anticancer agents: a patent review (2014-2018).
Mahboubi Rabbani SMI; Zarghi A
Expert Opin Ther Pat; 2019 Jun; 29(6):407-427. PubMed ID: 31132889
[TBL] [Abstract][Full Text] [Related]
2. COX inhibitors: a patent review (2011 - 2014).
Consalvi S; Biava M; Poce G
Expert Opin Ther Pat; 2015; 25(12):1357-71. PubMed ID: 26566186
[TBL] [Abstract][Full Text] [Related]
3. Alkaloids as Cyclooxygenase Inhibitors in Anticancer Drug Discovery.
Hashmi MA; Khan A; Farooq U; Khan S
Curr Protein Pept Sci; 2018; 19(3):292-301. PubMed ID: 28059042
[TBL] [Abstract][Full Text] [Related]
4. Cyclooxygenase-2 inhibitors: a literature and patent review (2009 - 2010).
Jawabrah Al-Hourani B; Sharma SK; Suresh M; Wuest F
Expert Opin Ther Pat; 2011 Sep; 21(9):1339-432. PubMed ID: 21714592
[TBL] [Abstract][Full Text] [Related]
5. The discovery and development of cyclooxygenase-2 inhibitors as potential anticancer therapies.
Vosooghi M; Amini M
Expert Opin Drug Discov; 2014 Mar; 9(3):255-67. PubMed ID: 24483845
[TBL] [Abstract][Full Text] [Related]
6. The search for new COX-2 inhibitors: a review of 2002 - 2008 patents.
Ramalho TC; Rocha M; da Cunha EF; Freitas MP
Expert Opin Ther Pat; 2009 Sep; 19(9):1193-228. PubMed ID: 19563267
[TBL] [Abstract][Full Text] [Related]
7. Biology of Cox-2: an application in cancer therapeutics.
Khan Z; Khan N; Tiwari RP; Sah NK; Prasad GB; Bisen PS
Curr Drug Targets; 2011 Jun; 12(7):1082-93. PubMed ID: 21443470
[TBL] [Abstract][Full Text] [Related]
8. Natural-Derived COX-2 Inhibitors as Anticancer Drugs: A Review of their Structural Diversity and Mechanism of Action.
Mahboubi-Rabbani M; Abbasi M; Zarghi A
Anticancer Agents Med Chem; 2023; 23(1):15-36. PubMed ID: 35638275
[TBL] [Abstract][Full Text] [Related]
9. Design and synthesis of benzimidazole analogs endowed with oxadiazole as selective COX-2 inhibitor.
Rathore A; Rahman MU; Siddiqui AA; Ali A; Shaharyar M
Arch Pharm (Weinheim); 2014 Dec; 347(12):923-35. PubMed ID: 25303727
[TBL] [Abstract][Full Text] [Related]
10. Update on COX-2 Selective Inhibitors: Chemical Classification, Side Effects and their Use in Cancers and Neuronal Diseases.
Rayar AM; Lagarde N; Ferroud C; Zagury JF; Montes M; Sylla-Iyarreta Veitia M
Curr Top Med Chem; 2017; 17(26):2935-2956. PubMed ID: 28828990
[TBL] [Abstract][Full Text] [Related]
11. Novel acid-type cyclooxygenase-2 inhibitors: Design, synthesis, and structure-activity relationship for anti-inflammatory drug.
Hayashi S; Ueno N; Murase A; Nakagawa Y; Takada J
Eur J Med Chem; 2012 Apr; 50():179-95. PubMed ID: 22373734
[TBL] [Abstract][Full Text] [Related]
12. Cyclooxygenase-2 as a target for anticancer drug development.
Méric JB; Rottey S; Olaussen K; Soria JC; Khayat D; Rixe O; Spano JP
Crit Rev Oncol Hematol; 2006 Jul; 59(1):51-64. PubMed ID: 16531064
[TBL] [Abstract][Full Text] [Related]
13. Cyclo-oxygenase-2 and its inhibition in cancer: is there a role?
Liao Z; Mason KA; Milas L
Drugs; 2007; 67(6):821-45. PubMed ID: 17428102
[TBL] [Abstract][Full Text] [Related]
14. Selective cyclooxygenase-2 (COX-2) inhibitors used for preventing or regressing cancer.
de Souza Pereira R
Recent Pat Anticancer Drug Discov; 2009 Jun; 4(2):157-63. PubMed ID: 19519538
[TBL] [Abstract][Full Text] [Related]
15. Adverse effects of COX-2 inhibitors.
Sharma JN; Jawad NM
ScientificWorldJournal; 2005 Aug; 5():629-45. PubMed ID: 16113940
[TBL] [Abstract][Full Text] [Related]
16. The pathophysiologic role of cyclo-oxygenases in the eye.
Radi ZA; Render JA
J Ocul Pharmacol Ther; 2008 Apr; 24(2):141-51. PubMed ID: 18355129
[TBL] [Abstract][Full Text] [Related]
17. The function of the selective inhibitors of cyclooxygenase 2.
Luan Y; Xu W
Mini Rev Med Chem; 2006 Dec; 6(12):1375-81. PubMed ID: 17168813
[TBL] [Abstract][Full Text] [Related]
18. Design, synthesis and structure-activity relationship studies of novel and diverse cyclooxygenase-2 inhibitors as anti-inflammatory drugs.
Hayashi S; Ueno N; Murase A; Takada J
J Enzyme Inhib Med Chem; 2014 Dec; 29(6):846-67. PubMed ID: 24517373
[TBL] [Abstract][Full Text] [Related]
19. Dual-target inhibitors based on COX-2: a review from medicinal chemistry perspectives.
Zhang F; Zhu G; Li Y; Qi Y; Wang Z; Li W
Future Med Chem; 2023 Dec; 15(23):2209-2233. PubMed ID: 38095081
[TBL] [Abstract][Full Text] [Related]
20. Mechanisms leading to COX-2 expression and COX-2 induced tumorigenesis: topical therapeutic strategies targeting COX-2 expression and activity.
Telliez A; Furman C; Pommery N; Hénichart JP
Anticancer Agents Med Chem; 2006 May; 6(3):187-208. PubMed ID: 16712448
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
